Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
02:30:00 03/12/2024 am IST
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/25/01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/25/01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 15.59L 13.35L 12.49L 11.43L 21.46L 15Cr 21.74L 1.48Cr 57.55L 7.49Cr 58.52L 57.25L 25Cr | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -3.24Cr -2.77Cr -2.6Cr -2.38Cr -4.46Cr -309.79Cr -4.52Cr -31Cr -12Cr -155.62Cr -12Cr -12Cr -514.74Cr | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.06% | 15.59L | |
| +1.09% | +5.26% | +4.44% | +26.03% | 5.16TCr | |
| -1.07% | +2.82% | +474.18% | +601.24% | 4.49TCr | |
| +1.47% | +9.79% | +40.15% | +21.21% | 4.28TCr | |
| +1.44% | +7.77% | +19.27% | +90.94% | 4.26TCr | |
| -0.93% | -4.33% | +17.87% | +51.96% | 3.18TCr | |
| +1.32% | +7.30% | +36.93% | +152.36% | 1.73TCr | |
| -0.60% | +1.93% | - | - | 1.66TCr | |
| +0.03% | +3.41% | +7.12% | +35.49% | 1.48TCr | |
| +1.28% | +5.41% | +91.01% | +46.93% | 1.41TCr | |
| Average | -2.01% | +1.41% | +76.77% | +103.90% | 2.76TCr | |
| Weighted average by Cap. | +0.49% | +4.72% | +102.56% | +148.52% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 14.9L 12.76L 11.94L 10.93L 20.52L 14Cr 20.79L 1.41Cr 55.02L 7.16Cr 55.95L 54.73L 24Cr | 8L 7L 6L 6L 10.81L 7.51Cr 10.95L 74.34L 28.99L 3.77Cr 29.48L 28.83L 12Cr |
| Net income | -4.42Cr -3.78Cr -3.54Cr -3.24Cr -6.08Cr -422.62Cr -6.16Cr -42Cr -16Cr -212.3Cr -17Cr -16Cr -702.2Cr | -3.95Cr -3.38Cr -3.16Cr -2.9Cr -5.44Cr -377.73Cr -5.51Cr -37Cr -15Cr -189.75Cr -15Cr -15Cr -627.62Cr |
| Net Debt | -6.36Cr -5.45Cr -5.1Cr -4.67Cr -8.76Cr -608.87Cr -8.88Cr -60Cr -23Cr -305.87Cr -24Cr -23Cr -1.01TCr | -3.39Cr -2.91Cr -2.72Cr -2.49Cr -4.67Cr -324.71Cr -4.73Cr -32Cr -13Cr -163.12Cr -13Cr -12Cr -539.52Cr |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
